HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$2.46
Day range
$2.21 - $2.46
Year range
$0.62 - $4.32
Market cap
461.16M USD
Avg Volume
3.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 3.41M | -27.52% |
Operating expense | 27.74M | 30.45% |
Net income | -24.06M | -36.54% |
Net profit margin | -705.39 | -88.38% |
Earnings per share | -0.10 | 64.99% |
EBITDA | -24.00M | -47.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 123.98M | 95.47% |
Total assets | 153.00M | 50.59% |
Total liabilities | 99.15M | -14.93% |
Total equity | 53.85M | — |
Shares outstanding | 187.02M | — |
Price to book | 8.48 | — |
Return on assets | -37.35% | — |
Return on capital | -48.26% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -24.06M | -36.54% |
Cash from operations | -19.80M | 1.92% |
Cash from investing | -140.00K | 96.41% |
Cash from financing | -22.00K | 94.05% |
Net change in cash | -19.96M | 18.38% |
Free cash flow | -10.70M | 51.51% |
About
Founded
2019
Headquarters
Website
Employees
52